Chronic thromboembolic pulmonary hypertension – surgical treatment options and our experience
Abstract
Background: Chronic thromboembolic pulmonary hypertension is an increasingly recognized cause of pulmonary hypertension. Th e prognosis of untreated patients is poor. Th e treatment of choice is the potentially curative pulmonary endarterectomy, which is feasible in more than half of the cases. Th e advances in operative techniques make pulmonary endarterectomy possible even in patients with very peripheral thromboemboli in the subsegmental arteries. Due to rarity of the disease it is advisable to perform the procedure in experienced specialized centers with high frequency of operations and thus low perioperative risk. Patients with persistent pulmonary hypertension aft er surgery and patients who have inoperable disease can be treated with vasodilators and remodulators of pulmonary vasculature, which improve prognosis to some extent. Th e fi nal treatment option is lung transplantation. Conclusions: Patients with chronic tromboembolic pulmonary hypertension have to be evaluated by a consultant surgeon with experience in pulmonary endarterectomy. In the last year two Slovenian patients were referred from our clinic to the University hospital in Vienna for pulmonary endarterectomy. Th e treatment was successful with good followup results.Downloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
